Q-Switched Nd:YAG in Macular Amyloidosis

Phase 1

Completed

• Conditions: Macular Amyloidosis

• Registration Number: NCT00353392
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

The purpose of this study is to determine whether Q-Switched Nd:YAG Laser therapy are effective in reduction of Cutaneous macular amyloidosis.

Detailed Description

We treat the macular amyloidosis cases by Q-Switched Nd:YAG Laser and compare the before and after treatment situation by the photos and colorimetric assessment.

Study Timeline

• Study Start: 2006-03
• Primary Completion: 2006-07
• Study First Submitted: 2006-07-17
• Study First Submitted QC: 2006-07-17
• Study First Posted: 2006-07-18
• Study Completion: 2006-08
• Status Verified: 2006-11
• Last Update Submitted: 2013-12-18
• Last Update Posted: 2013-12-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• Macular amyloidosis confirmed cases

Exclusion Criteria

• Pregnancy and breast feeding
• Over 18 years old

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Visual and colorimetric assessment

Trial Locations

Locations (1)

Skin Research Center, Shaheed Beheshti Medical University; 🇮🇷 Tehran, Iran, Islamic Republic of